1. Home
  2. KORE vs ITRM Comparison

KORE vs ITRM Comparison

Compare KORE & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • ITRM
  • Stock Information
  • Founded
  • KORE 2003
  • ITRM 2015
  • Country
  • KORE United States
  • ITRM Ireland
  • Employees
  • KORE N/A
  • ITRM N/A
  • Industry
  • KORE Telecommunications Equipment
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • ITRM Health Care
  • Exchange
  • KORE Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • KORE 45.0M
  • ITRM 40.0M
  • IPO Year
  • KORE N/A
  • ITRM 2018
  • Fundamental
  • Price
  • KORE $4.21
  • ITRM $0.61
  • Analyst Decision
  • KORE Hold
  • ITRM Strong Buy
  • Analyst Count
  • KORE 2
  • ITRM 1
  • Target Price
  • KORE $2.75
  • ITRM $9.00
  • AVG Volume (30 Days)
  • KORE 211.4K
  • ITRM 985.2K
  • Earning Date
  • KORE 11-12-2025
  • ITRM 11-12-2025
  • Dividend Yield
  • KORE N/A
  • ITRM N/A
  • EPS Growth
  • KORE N/A
  • ITRM N/A
  • EPS
  • KORE N/A
  • ITRM N/A
  • Revenue
  • KORE $285,636,000.00
  • ITRM N/A
  • Revenue This Year
  • KORE $4.46
  • ITRM N/A
  • Revenue Next Year
  • KORE $5.94
  • ITRM $482.25
  • P/E Ratio
  • KORE N/A
  • ITRM N/A
  • Revenue Growth
  • KORE 0.24
  • ITRM N/A
  • 52 Week Low
  • KORE $1.10
  • ITRM $0.61
  • 52 Week High
  • KORE $4.88
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • KORE 76.68
  • ITRM 36.47
  • Support Level
  • KORE $3.35
  • ITRM $0.64
  • Resistance Level
  • KORE $3.83
  • ITRM $0.70
  • Average True Range (ATR)
  • KORE 0.29
  • ITRM 0.04
  • MACD
  • KORE 0.07
  • ITRM -0.01
  • Stochastic Oscillator
  • KORE 85.30
  • ITRM 0.00

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: